Direct-to-consumer approach yields 4,000+ new sign-ups & higher user-engagement results DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today that user-engagement metrics were higher during November 2016 when compared to the month...
|
Strong consumable and recurring subscription revenues drive quarterly financial results and provide foundation for future growth DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today reported financial and operational results for the three and nine month periods ended September...
|
Earnings and Business Update Conference Call Scheduled for 9:00am EST DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, announced...
|
More than 10,000 Dario smart meters sold in the U.S. DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, today...
|
Collaborative partnership with A&D Medical and Diabetes Express to expand distribution of Dario in Canada with online platform for sales and prescription processing DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution, today announced the launch of an...
|
Agility to Navigate Complex Mobile Ecosystem Showcases DarioHealth's Versatility DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced that it is adapting its flagship product to also incorporate use with the new Apple®...
|
Revenues More than Double Year-over-Year; DarioHealth Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today reported financial and operational results for the three and six month period ended June 30,...
|
Jul 28, 2016 Broader Reach via Digital Marketing Strategy Higher Product Margins DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario(TM) Smart Diabetes Management Solution, today announced that it has begun...
|
Jul 27, 2016 Company Announces Corporate Name Change to DarioHealth Corp. to Reflect Expansion of Comprehensive Digital Health and Lifestyle Offering Labstyle Innovations Corp. (NASDAQ: DRIO) - a leader in digital health and mobile health solutions - announced today that it is changing its corporate name to DarioHealth Corp. The name change...
|
Jul 21, 2016 Expands Reach to Pharmacies and Durable Medical Dealers Access on Commercial Health Plans LabStyle Innovations Corp. (NASDAQ:DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an agreement with GEMCO Medical, an established healthcare...
|
Jul 19, 2016 Direct-to-Consumer Digital Marketing Strategy Driving Rapid Initial Market Penetration LabStyle Innovations (NASDAQ: DRIO) - a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution - today announced that since the...
|
Jul 11, 2016 Dario Smart Diabetes Management Solution to reach thousands of college students across the U.S. LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced it has joined the College Diabetes Network (CDN) as a Corporate Member. Since its...
|
May 27, 2016 LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that the Company's Chief Financial Officer, Zvi Ben-David will present at the Marcum...
|
May 11, 2016 84% increase in sequential quarterly revenues Quarterly gross loss narrowed 61% compared to Q4 2015 Net loss narrowed by 29% compared to Q4 2015 Launched Dario Blood Glucose Monitoring System in the United States late in the first quarter...
|
May 5, 2016 LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that it has been granted a key patent by the European Patent Office (EPO) for the...
|
Mar 23, 2016 ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times...
|
Mar 15, 2016 World's largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the...
|
Mar 9, 2016 Broadens platform technology's applications beyond mHealth and into health and non-health related industrial markets LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038...
|
Mar 4, 2016 Company Effects a 1-for-18 Reverse Stock Split LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective...
|
Feb 9, 2016 - FDA clearance announced on December 22nd LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an...
|
Jan 26, 2016 - Sales channels to include direct-to-consumer, e-commerce, third-party distributors
CAESAREA, Israel / LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the...
|
|